SpiNNaker computer mimics the human brain’s neural networks

A custom-built computer, dubbed SpiNNaker, which mimics the brain’s neural networks, is helping researchers learn more about conditions including epilepsy and Alzheimer’s disease.

"SpiNNaker can support detailed biological models of the cortex--the outer layer of the brain that receives and processes information from the senses--delivering results very similar to those from an equivalent supercomputer software simulation," van Albada said. "The ability to run large-scale detailed neural networks quickly and at low power consumption will advance robotics research and facilitate studies on learning and brain disorders."

The researchers, led by Sacha van Albada, PhD, of the Jülich Research Centre in Jülich, Germany, tested the SpiNNaker for accuracy, speed and energy efficiency against NEST—a supercomputer software currently utilized for brain neuron-signaling research. Results of the study were published in Frontiers of Neuroscience.

The researchers found similar results between SpiNNaker and NEST—with the SpiNNaker using only 1 percent of its total capability. SpiNNaker had a similar accuracy, energy consumption to that of NEST.

In development for more than 15 years, SpiNNaker includes a half-million simple computing elements controlled by its own software.

“Our results widen the application domain of SpiNNaker and help guide its development, showing that further optimizations such as synapse-centric network representation are necessary to enable real-time simulation of large biological neural networks,” van Albada et al wrote.

The researchers noted they look to further improve the software for efficiency.

""

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”